| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.6 |